Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$7.33 - $9.39 $13.9 Million - $17.8 Million
-1,897,506 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$7.9 - $10.19 $5.73 Million - $7.39 Million
-725,525 Reduced 27.66%
1,897,506 $15.2 Million
Q3 2021

Nov 12, 2021

SELL
$8.38 - $10.18 $2.93 Million - $3.56 Million
-350,061 Reduced 11.77%
2,623,031 $25.5 Million
Q2 2021

Aug 13, 2021

SELL
$9.9 - $11.56 $6.94 Million - $8.1 Million
-701,012 Reduced 19.08%
2,973,092 $29.4 Million
Q1 2021

May 17, 2021

BUY
$10.34 - $12.81 $2.92 Million - $3.62 Million
282,692 Added 8.34%
3,674,104 $42.4 Million
Q4 2020

Feb 16, 2021

BUY
$8.61 - $11.04 $13.2 Million - $16.9 Million
1,531,387 Added 82.33%
3,391,412 $32.7 Million
Q3 2020

Nov 13, 2020

SELL
$8.57 - $12.69 $1.92 Million - $2.84 Million
-224,078 Reduced 10.75%
1,860,025 $16.8 Million
Q2 2020

Aug 14, 2020

BUY
$8.12 - $13.12 $1.96 Million - $3.16 Million
240,857 Added 13.07%
2,084,103 $25.7 Million
Q1 2020

May 15, 2020

BUY
$6.69 - $13.45 $1.25 Million - $2.52 Million
187,075 Added 11.3%
1,843,246 $16.6 Million
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $4.49 Million - $7.36 Million
686,941 Added 70.87%
1,656,171 $16.2 Million
Q3 2019

Nov 14, 2019

SELL
$6.16 - $9.6 $18,504 - $28,838
-3,004 Reduced 0.31%
969,230 $6.67 Million
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $5.35 Million - $10.4 Million
659,351 Added 210.73%
972,234 $8.97 Million
Q1 2019

May 15, 2019

BUY
$15.58 - $20.01 $502,860 - $645,842
32,276 Added 11.5%
312,883 $4.91 Million
Q4 2018

Feb 14, 2019

BUY
$14.59 - $23.84 $4.09 Million - $6.69 Million
280,607 New
280,607 $4.33 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track First Light Asset Management, LLC Portfolio

Follow First Light Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Light Asset Management, LLC with notifications on news.